Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The cash and debt free consideration value is €370 million.
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Global pharmaceutical company having a surgical business concept incepted in Dubai
Ayúdame3D has become a leading social entity in social technology.
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Subscribe To Our Newsletter & Stay Updated
